A positive methamphetamine screen and a confirmed methamphetamine concentration are different findings. Evaluating a laboratory packet requires identifying which analytical step supports each statement in the final report.
A published example of the sequence
In Lemos’s 2009 two-case driving report, blood underwent an enzyme-linked immunosorbent screening panel. Following a positive methamphetamine screen, a fresh aliquot was extracted and analyzed by gas chromatography–mass spectrometry using deuterated internal standards and quantitative calibrators.
The paper therefore described more than a presumptive screen. It reported a subsequent analytical process used to identify and quantify methamphetamine and amphetamine. That historical example does not mean every laboratory follows the same workflow.
Confirmation still requires method-specific scrutiny
Logan’s 2002 review discusses challenges in gas chromatographic identification, including structural similarities, chromatographic behavior and the need to assess retention information together with mass spectra. A mass spectrometer’s presence alone does not explain whether the laboratory met its identification criteria.
The appropriate record includes the validated method, calibrations, controls, chromatograms, identification criteria and the results relevant to the tested specimen. A case report can describe a method but cannot substitute for the actual case’s analytical records.
Negative panels have defined scope
Lemos reported negative findings on the other screens performed. That statement is limited to the included analytes and the capabilities of those methods. It does not establish that every possible substance was absent.
Similarly, the laboratory’s reporting limit is part of the result. An analyte not reported above a threshold should not automatically be described as absolutely absent, and screening results should not be treated as quantitative confirmations.
Keep the conclusion within the measurement
Record the specimen type, collection time, units, analytes and analytical uncertainty where available. Then separate chemical identification from interpretation. Confirmation can strengthen evidence that an analyte was present in the specimen; it does not independently establish the source, dose, time of administration or degree of impairment during earlier driving.
The central question is whether the disclosed data support the laboratory’s exact claim. Analytical accuracy and the subsequent behavioral inference each require their own justification.
Scientific sources
Lemos NP. Methamphetamine and driving. Science and Justice. 2009;49:247–249. Case report.
Logan BK. Methamphetamine—Effects on Human Performance and Behavior. Forensic Science Review. 2002;14(1–2):133–151. Historical review.
Leave a Reply